Evidence map›Paper›PMID 41351727›Full record

ArticleHealth care analysis : HCA : journal of health philosophy and policy2026

The 3D Value Framework for Sustainable Access to Effective Antibiotics.

Anders Herlitz, Erik Malmqvist, Christian Munthe

Abstract read
In one paragraph

Article in Health care analysis : HCA : journal of health philosophy and policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anders HerlitzDepartment of philosophy, Lund University, Lund, Sweden.
Erik MalmqvistPhilosophy, linguistics and theory of science, University of Gothenburg, Gothenburg, Sweden.
Christian MunthePhilosophy, linguistics and theory of science, University of Gothenburg, Gothenburg, Sweden. christian.munthe@gu.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sustainable access to effective antibiotics is a main rationale for addressing antimicrobial resistance, for calls to enhance antibiotic supply security and for development support to promote health system capacity in low- and middle-income settings. Standard models for valuing pharmaceuticals fail to capture the full value of sustainable access to effective antibiotics. In effect, assessments of societal or corporate investments to promote such access underestimate their value and the cost of foregoing them. In effect, measures that could address existing sustainability problems in antibiotic supply systems are hampered. We review the features needed to avoid these problems and assess suggestions to address the flaws of existing approaches, such as the STEDI-model. On this basis, we propose the 3D Value Framework, a straightforward and comprehensive model that focusses directly on what types of valuable outcomes there can be related to having sustainable access to effective antibiotics. We also sketch how this model can be used in cost-effectiveness analysis grounding public decision-making and discuss further applications in other settings.

Indexed as

Anti-Bacterial AgentsHealth Services AccessibilityCost-Benefit AnalysisCost-Effectiveness AnalysisDrug Resistance, MicrobialHealth PolicyHumansAnti-Bacterial AgentsAntibioticsAntimicrobial resistanceCost-effectiveness analysisHealthcare accessHealth policySustainabilityValue

Identifiers

PMID41351727
PMCPMC13675264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.